Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • AbstractFemale and male very elderly intensive patients (VIPs) might differ in characteristics and outcomes. We aimed to compare female versus male VIPs in a large, multinational collective of VIPs with regards to outcome and predictors of mortality. In total, 7555 patients were included in this analysis, 3973 (53%) male and 3582 (47%) female patients. The primary endpoint was 30-day-mortality. Baseline characteristics, data on management and geriatric scores including frailty assessed by Clinical Frailty Scale (CFS) were documented. Two propensity scores (for being male) were obtained for consecutive matching, score 1 for baseline characteristics and score 2 for baseline characteristics and ICU management. Male VIPs were younger (83 ± 5 vs. 84 ± 5; p < 0.001), less often frail (CFS > 4; 38% versus 49%; p < 0.001) but evidenced higher SOFA (7 ± 6 versus 6 ± 6 points; p < 0.001) scores. After propensity score matching, no differences in baseline characteristics could be observed. In the paired analysis, the mortality in male VIPs was higher (mean difference 3.34% 95%CI 0.92–5.76%; p = 0.007) compared to females. In both multivariable logistic regression models correcting for propensity score 1 (aOR 1.15 95%CI 1.03–1.27; p = 0.007) and propensity score 2 (aOR 1.15 95%CI 1.04–1.27; p = 0.007) male sex was independently associated with higher odds for 30-day-mortality. Of note, male gender was not associated with ICU mortality (OR 1.08 95%CI 0.98–1.19; p = 0.14). Outcomes of elderly intensive care patients evidenced independent sex differences. Male sex was associated with adverse 30-day-mortality but not ICU-mortality. Further research to identify potential sex-specific risk factors after ICU discharge is warranted.Trial registration: NCT03134807 and NCT03370692; Registered on May 1, 2017 https://clinicaltrials.gov/ct2/show/NCT03370692.

authors

  • Wernly, Bernhard
  • Bruno, Raphael Romano
  • Kelm, Malte
  • Boumendil, Ariane
  • Morandi, Alessandro
  • Andersen, Finn H
  • Artigas, Antonio
  • Finazzi, Stefano
  • Cecconi, Maurizio
  • Christensen, Steffen
  • Faraldi, Loredana
  • Lichtenauer, Michael
  • Muessig, Johanna M
  • Marsh, Brian
  • Moreno, Rui
  • Oeyen, Sandra
  • Öhman, Christina Agvald
  • Pinto, Bernado Bollen
  • Soliman, Ivo W
  • Szczeklik, Wojciech
  • Niederseer, David
  • Valentin, Andreas
  • Watson, Ximena
  • Leaver, Susannah
  • Boulanger, Carole
  • Walther, Sten
  • Schefold, Joerg C
  • Joannidis, Michael
  • Nalapko, Yuriy
  • Elhadi, Muhammed
  • Fjølner, Jesper
  • Zafeiridis, Tilemachos
  • De Lange, Dylan W
  • Guidet, Bertrand
  • Flaatten, Hans
  • Jung, Christian

publication date

  • December 2020